Eli Lilly to Spend $3.5 Billion on New U.S. Plant for Next-Gen Obesity Drugs
Eli Lilly is doubling down on its push to dominate the fast-growing obesity drug market. The pharmaceutical giant announced plans
Big Pharma Races to Snap Up Biotech Assets as $170 Billion Patent Cliff Nears
Global pharmaceutical giants are accelerating efforts to acquire biotech companies and late-stage drug assets as the industry braces for a